Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Motor complications in Parkinson's disease: ten year follow-up study.

Identifieur interne : 002E93 ( Ncbi/Curation ); précédent : 002E92; suivant : 002E94

Motor complications in Parkinson's disease: ten year follow-up study.

Auteurs : Iria Cabo L Pez [Espagne] ; Pedro J García Ruiz ; Silvia Vázquez Fernández Del Pozo ; Vicenta Sánchez Bernardos

Source :

RBID : pubmed:20931632

English descriptors

Abstract

Parkinson's disease (PD) can be symptomatically controlled with standard treatments; however, after a few years, this response typically declines and most patients develop motor complications. We carried out a prospective practice-based study to evaluate the evolution appearance and evolution of motor complications in 64 de novo PD patients over 5 years and in 38 PD patients over 10 years. We studied untreated patients from initial assessment at basal conditions and evaluated every 6 months thereafter with treatment (levodopa versus other drugs). The follow-up assessments were performed with the Unified Parkinson's Disease Rating Scale (UPDRS). At each assessment, patients were monitored regarding the development of dyskinesias, motor fluctuations, freezing, loss of postural reflexes, and cognitive impairment. We observed a significant improvement in UPDRS scores during the first year, then a progressive decline, more evident after the third year. Motor complications increased after the third year, and at the end of the survey (tenth year); drug-induced dyskinesias and motor fluctuations were experienced (71.1 and 94.7%, respectively). After the first decade, many complications arose from the non-levodopa-responsive features of the disease (cognitive impairment was present in 52.6% and gait freezing in 71.1%). Initial medication may influence medium-term complications but not long-term problems. Most long-term disabling problems of PD were related to non-levodopa-responsive features.

DOI: 10.1002/mds.23219
PubMed: 20931632

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:20931632

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Motor complications in Parkinson's disease: ten year follow-up study.</title>
<author>
<name sortKey="L Pez, Iria Cabo" sort="L Pez, Iria Cabo" uniqKey="L Pez I" first="Iria Cabo" last="L Pez">Iria Cabo L Pez</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain. icabol@yahoo.es</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology, Fundación Jiménez Díaz, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ruiz, Pedro J Garcia" sort="Ruiz, Pedro J Garcia" uniqKey="Ruiz P" first="Pedro J García" last="Ruiz">Pedro J García Ruiz</name>
</author>
<author>
<name sortKey="Del Pozo, Silvia Vazquez Fernandez" sort="Del Pozo, Silvia Vazquez Fernandez" uniqKey="Del Pozo S" first="Silvia Vázquez Fernández" last="Del Pozo">Silvia Vázquez Fernández Del Pozo</name>
</author>
<author>
<name sortKey="Bernardos, Vicenta Sanchez" sort="Bernardos, Vicenta Sanchez" uniqKey="Bernardos V" first="Vicenta Sánchez" last="Bernardos">Vicenta Sánchez Bernardos</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.23219</idno>
<idno type="RBID">pubmed:20931632</idno>
<idno type="pmid">20931632</idno>
<idno type="wicri:Area/PubMed/Corpus">001524</idno>
<idno type="wicri:Area/PubMed/Curation">001524</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001771</idno>
<idno type="wicri:Area/Ncbi/Merge">002E93</idno>
<idno type="wicri:Area/Ncbi/Curation">002E93</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Motor complications in Parkinson's disease: ten year follow-up study.</title>
<author>
<name sortKey="L Pez, Iria Cabo" sort="L Pez, Iria Cabo" uniqKey="L Pez I" first="Iria Cabo" last="L Pez">Iria Cabo L Pez</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain. icabol@yahoo.es</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology, Fundación Jiménez Díaz, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ruiz, Pedro J Garcia" sort="Ruiz, Pedro J Garcia" uniqKey="Ruiz P" first="Pedro J García" last="Ruiz">Pedro J García Ruiz</name>
</author>
<author>
<name sortKey="Del Pozo, Silvia Vazquez Fernandez" sort="Del Pozo, Silvia Vazquez Fernandez" uniqKey="Del Pozo S" first="Silvia Vázquez Fernández" last="Del Pozo">Silvia Vázquez Fernández Del Pozo</name>
</author>
<author>
<name sortKey="Bernardos, Vicenta Sanchez" sort="Bernardos, Vicenta Sanchez" uniqKey="Bernardos V" first="Vicenta Sánchez" last="Bernardos">Vicenta Sánchez Bernardos</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Disease Progression</term>
<term>Dyskinesias (complications)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motor Activity</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Prospective Studies</term>
<term>Severity of Illness Index</term>
<term>Statistics, Nonparametric</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Dyskinesias</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motor Activity</term>
<term>Prospective Studies</term>
<term>Severity of Illness Index</term>
<term>Statistics, Nonparametric</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson's disease (PD) can be symptomatically controlled with standard treatments; however, after a few years, this response typically declines and most patients develop motor complications. We carried out a prospective practice-based study to evaluate the evolution appearance and evolution of motor complications in 64 de novo PD patients over 5 years and in 38 PD patients over 10 years. We studied untreated patients from initial assessment at basal conditions and evaluated every 6 months thereafter with treatment (levodopa versus other drugs). The follow-up assessments were performed with the Unified Parkinson's Disease Rating Scale (UPDRS). At each assessment, patients were monitored regarding the development of dyskinesias, motor fluctuations, freezing, loss of postural reflexes, and cognitive impairment. We observed a significant improvement in UPDRS scores during the first year, then a progressive decline, more evident after the third year. Motor complications increased after the third year, and at the end of the survey (tenth year); drug-induced dyskinesias and motor fluctuations were experienced (71.1 and 94.7%, respectively). After the first decade, many complications arose from the non-levodopa-responsive features of the disease (cognitive impairment was present in 52.6% and gait freezing in 71.1%). Initial medication may influence medium-term complications but not long-term problems. Most long-term disabling problems of PD were related to non-levodopa-responsive features.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E93 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 002E93 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:20931632
   |texte=   Motor complications in Parkinson's disease: ten year follow-up study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:20931632" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024